- AstraZeneca - ADCC Compound Library RFP
- R01: Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (PA-16-374)
- R21: High Throughput Screening to Discover Chemical Probes (PAR-14-283)
- R01: High Throughput Screening to Discover Chemical Probes (PAR-14-284)
- R01: Discovery of in vivo Chemical Probes (PAR-14-279)
- R01:Building on High Impact Basic Neurobiology Through Assay Development: Advancing Tools for Therapeutic Discovery
- R21/R33:Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery
- R21/R33:Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Pharmacodynamics and In vivo Efficacy Studies for Small Molecules and Biologics/Biotechnology Products
- R01: Drug Discovery for Nervous System Disorders
- R21: Drug Discovery for Nervous System Disorders
- Bayer Grants4Targets Program